Kazia Therapeutics Limited
KZIANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $24.37M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.86$17.40
- Volume (live)
- -
- Avg. volume (3M)
- 261.78K
Kazia Therapeutics (KZIA) Stock Price & Financial Analysis
Kazia Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.48 - $8.06 |
|---|---|
| 52-Week High | $17.40 |
| 52-Week Low | $4.86 |
| Open | $7.98 |
| Volume (last close) | 52.67K |
| Average Volume (3M) | 261.78K |
| Revenue (TTM) | 1.78M |
|---|---|
| Net Income (TTM) | -35.66M |
| Free Cash Flow (TTM) | -17.46M |
| EPS (TTM) | −$23.39 |
| Profit Margin | -2008.78% |
| Operating Margin | -1866.72% |
| Return on Equity (ROE) | -109.07% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jan 28, 2013 |
| Market Cap | 24.37M |
|---|---|
| Shares Outstanding | 3.12M |
| Price to Sales (P/S) | 13.73 |
| Price to Book (P/B) | 0.75 |
| EV/EBITDA | 0.74 |
| 50-Day MA | $11.10 |
|---|---|
| 200-Day MA | $10.48 |
| 1-Year Change | +19.73% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Kazia Therapeutics at a Glance
As of the Oct 23, 2026 close, Kazia Therapeutics (KZIA) has a market capitalization of $24.37M. The stock trades at 13.7× sales. Over the trailing twelve months it lost $35.66M on revenue of $1.78M and burned $17.46M of free cash flow. Revenue fell 98.2% year over year.
As of its latest reported balance sheet, it holds $48.87M in cash and securities against $69.52K of debt, a net cash position of $48.80M.
Kazia Therapeutics does not currently pay a dividend.
The share price is up 19.7% over the past year. At $7.81 (the Oct 23, 2026 close) it sits within its 52-week range of $4.86 to $17.40, below its 200-day moving average of $10.48.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $30.40, 289.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Kazia Therapeutics
What is the current stock price for KZIA?
As of the Oct 23, 2026 close, KZIA stock trades at $7.81. The 52-week range is $4.86–$17.40, with a day range of $7.48–$8.06.
What is the P/E ratio for KZIA?
The P/E ratio (Price-to-Earnings) for KZIA is shown in the Key Statistics section. This valuation metric helps compare Kazia Therapeutics Limited to industry peers.
Does KZIA pay dividends?
Kazia Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for KZIA?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for KZIA is Buy. The average 12-month price target is $30.40, a 289.2% upside from the Oct 23, 2026 close of $7.81.
What is the market cap of KZIA?
As of the Oct 23, 2026 close, Kazia Therapeutics's market capitalization is $24.4M, classifying it as a micro-cap company. Kazia Therapeutics operates in the Healthcare sector within the Biotechnology industry.